Clinical Trial

Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure

Study acronym: TEAM-HF
Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of TEAM-HF IDE clinical trial is to evaluate safety and effectiveness of the HeartMate 3 LVAS compared to guideline directed medical therapy (GDMT) in a population of ambulatory advanced heart failure patients who are not dependent on intravenous inotrope.
Protocol Amendment History 1 change
notable Trial sites expanded: 63 -> 68 locations 2026-06-11
Trial Details
NCT Number NCT06526195
Lead Sponsor Abbott Medical Devices
Conditions Heart Failure, Heart Diseases, Cardiovascular Diseases, Pulmonary Hypertension
Enrollment 850 participants
Start Date 2024-12-13
Primary Completion 2029-09 (estimated)
Study Completion 2032-09 (estimated)
Updated on ClinicalTrials.gov 2026-06-10